To dissect the molecular mechanism of how hypoxia-induced TR4 can alter the RCC sunitinib resistance, we examined several genes that have been reported to play important roles on altering sunitinib sensitivity [4, 6, 16]. Here, NR2C2 is linked to renal cell carcinoma.